TIF Guidelines for the Management of Transfusion-Dependent β-Thalassemia
Musallam K., Cappellini M.D., Porter J., Farmakis D., Eleftheriou A., Angastiniotis M., Taher A.T. HemaSphere. (2025).
Assessing Disability in Thalassaemia: A Position Statement by the Thalassaemia International Federation
Farmakis, D., Angastiniotis, M., Papingiotis, G., Cannon, L., & Eleftheriou, A. European Journal of Haematology. (2024).
Exciting Science from the 16th International Conference on Thalassemia and Hemoglobinopathies
Farmakis D, Angastiniotis M, Eleftheriou A. Hemasphere. 2024 Jul 19;8(7):e114. doi: 10.1002/hem3.114. eCollection 2024 Jul.PMID: 39035105
Addressing Thalassaemia Management from Patients’ Perspectives: An International Collaborative Assessment
Economidou EC, Angastiniotis M, Avraam D, Soteriades ES, Eleftheriou A.Medicina (Kaunas). 2024 Apr 18;60(4):650. doi: 10.3390/medicina60040650.PMID: 38674296
Beta Thalassemia: Looking to The Future, Addressing Unmet Needs and Challenges
Angastiniotis M. Ann N Y Acad Sci. 2024 Feb;1532(1):63-72. doi: 10.1111/nyas.15097.
The Need for Translational Epidemiology in Beta Thalassemia Syndromes: A Thalassemia International Federation Perspective
Soteriades S, Angastiniotis M, Farmakis D, Eleftheriou A, Maggio A.Hematol Oncol Clin North Am. 2023 Apr;37(2):261-272. doi: 10.1016/j.hoc.2022.12.011.
Juggling between the Cost and Value of New Therapies: Does Science Still Serve Patient Needs?
Eleftheriou A., Farmakis D., Englezos P., Tuli S., Mylona E., et al. Thalassaemia Reports. 2023, 13(1), 33-37
TIF Standards for Haemoglobinopathy Reference Centres
Angastiniotis M., Eleftheriou A., Naveed M., Al Assaf A., Polynikis A., Soteriades E. and Farmakis D. Thalassaemia Reports. 2023, 13(1), 10-20.
Estimating the Cost of Thalassemia Care across the World: A Thalassemia International Federation Model
Eleftheriou A, Antoniou E, Darbà J, Ascanio M, Angastiniotis M, Farmakis D.Hemoglobin. 2022 Nov;46(6):308-311. doi: 10.1080/03630269.2023.2167657. Epub 2023 Feb 27.PMID: 36847683
Thalassaemia Registries: A Call for Action. A Position Statement from the Thalassaemia International Federation
Farmakis D, Angastiniotis M, El Ghoul MM, Cannon L, Eleftheriou A. Hemoglobin. 2022 Jul;46(4):225-232. doi: 10.1080/03630269.2022.2099285. Epub 2022 Aug 24.PMID: 36000583
2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia
Farmakis D, Porter J, Taher A, Domenica Cappellini M, Angastiniotis M, Eleftheriou A.Hemasphere. 2022 Jul 29;6(8): e732. doi: 10.1097/HS9.0000000000000732. eCollection 2022 Aug.PMID: 35928543
The Outcomes of Patients with Haemoglobin Disorders in Cyprus: A Joined Report of the Thalassaemia International Federation and the Nicosia and Paphos Thalassaemia Centres (State Health Services Organisation)
Angastiniotis M., Christou S., Kolnakou A., Pangalou E., Savvidou I., Farmakis D. and Eleftheriou A. Thalassaemia Reports. 2022, 12(4), 143-156.
COVID-19 Pandemic and The Great Impulse on Telemedicine: The Basis of the WONCA Europe Statement on Telemedicine at the WHO Europe 70th Regional Meeting September 2020
Petrazzuoli F, Kurpas D, Vinker S, Sarkisova V, Eleftheriou A, Żakowicz A, Aarendonk D, Ungan M.Prim Health Care Res Dev. 2021 Dec 13;22:e80. doi: 10.1017/S1463423621000633.PMID: 34895388
The Prevention of Thalassemia Revisited: A Historical and Ethical Perspective by the Thalassemia International Federation
Angastiniotis M, Petrou M, Loukopoulos D, Modell B, Farmakis D, Englezos P, Eleftheriou A. Hemoglobin. 2021 Jan; 45(1):5-12. doi: 10.1080/03630269.2021.1872612. Epub 2021 Jan 18.PMID: 33461349
Iranian Patients’ Attitudes to Current and Novel Therapies: A Patient Directed Survey
Hadipour M., Angastiniotis M., Hosoya S., Hashemi Bahremani F., Tabrizi Namini M. and Eleftheriou A. Thalassaemia Reports. 2021, 11(1), 9514; https://doi.org/10.4081/thal.2021.9514 – 17 Mar 2021
Thalassaemia Prior and Consequent to COVID-19 Pandemic. The Perspective of Thalassaemia International Federation (TIF)
Eleftheriou A., Cannon L. and Angastiniotis M.. Thalassaemia Reports. 2020, 10(1), 9138; https://doi.org/10.4081/thal.2020.9138 – 29 Jun 2020
COVID-19 and Thalassaemia in Iran
Hadipour M., Hosoya S., Hashemi Bahremani F., Tabrizi Namini M. and Eleftheriou A. Thalassaemia Reports. 2020, 10(1), 9157; https://doi.org/10.4081/thal.2020.9157 – 9 Jun 2020
COVID-19 and Thalassaemia: A Position Statement of the Thalassaemia International Federation
Farmakis D, Giakoumis A, Cannon L, Angastiniotis M, Eleftheriou A.Eur J Haematol. 2020 Oct;105(4):378-386. Doi: 10.1111/Ejh.13476. Epub 2020 Jul 13.PMID: 32573838 Free PMC Article.
The Changing Epidemiology of the Ageing Thalassaemia Populations: A Position Statement of the Thalassaemia International Federation
Farmakis D., Giakoumis A., Angastiniotis M., Eleftheriou A. Eur J Haematol. 2020 Jul;105(1):16-23. doi: 10.1111/ejh.13410. Epub 2020 Apr 15.PMID: 32198891
EHA Research Roadmap on Hemoglobinopathies and Thalassemia: An Update
Iolascon A., De Franceschi L., Muckenthaler M., Taher A., Rees D., de Montalembert M., Rivella S., Eleftheriou A., Cappellini MD. Hemasphere. 2019 Jun 4;3(3): e208. doi: 10.1097/HS9.0000000000000208. eCollection 2019 Jun.PMID: 31723835
Thalassemias: An Overview
Angastiniotis M., Lobitz S. Int J Neonatal Screen. 2019 Mar 20;5(1):16. doi: 10.3390/ijns5010016. eCollection. 2019.
Newborn Screening for Sickle Cell Disease in Europe: Recommendations from a Pan-European Consensus Conference
Lobitz S., Telfer P., Cela E., Allaf B., Angastiniotis M., Backman Johansson C. et al. Br J Haematology. 2018 Nov;183(4):648-660. doi: 10.1111/bjh.15600
Patient Care: Unmet Needs Globally
Angastiniotis M. and Eleftheriou A. Thalassaemia Reports. 2018, 8(1), 7485; https://doi.org/10.4081/thal.2018.7485 – 18 Apr 2018
TIF 2.0: The Thal e-Course and TIF Expert Patients’ Programme for Disease-Related Education and Self-Management Skills in Thalassaemia
Antoniadou V., Angastiniotis M. and Eleftheriou A. Thalassaemia Reports. 2018, 8(1), 7495.
Β-Thalassemia Distribution in the Old World: Αn Ancient Disease Seen from a Historical Standpoint
De Sanctis V., Kattamis C., Canatan D., Soliman AT., Elsedfy H., Karimi M., Daar S., Wali Y., Yassin M., Soliman N., et al. Mediterranean J. Hematol. Infect Dis. 2017 Feb 20;9(1): e2017018. doi: 10.4084/MJHID.2017.018. eCollection 2017.
The ICET-A Recommendations for the Diagnosis and Management of Disturbances of Glucose Homeostasis in Thalassemia Major Patients
De Sanctis V., Soliman AT., Elsedfy H., Yaarubi SA., Skordis N., Khater D., El Kholy M., Stoeva I., Fiscina B., Angastiniotis M., Daar S., Kattamis C. Mediterr J Hematol Infect Dis. 2016 Oct 28;8(1): e2016058. doi: 10.4084/MJHID.2016.058. eCollection 2016.
The Molecular Spectrum and Distribution of Haemoglobinopathies in Cyprus: A 20-Year Retrospective Study
Kountouris P., Kousiappa I., Papasavva T., Christopoulos G., Pavlou E., Petrou M., et al. Sci Rep. 2016 May 20;6:26371. doi: 10.1038/srep26371.
EMQN Haemoglobinopathies Best Practice Meeting. EMQN Best Practice Guidelines for Molecular and Haematology Methods for Carrier Identification and Prenatal Diagnosis of Haemoglobinopathies
Traeger-Synodinos J., Harteveld CL., Old JM., Petrou M., Galanello R., Giordano P., Angastioniotis M., De la Salle B., Henderson S., May A. Eur J Hum Genet. 2015 Apr;23(4):426-37. doi: 10.1038/ejhg.2014.131.
eHealth Services for the European Reference Network on Rare Anaemias (eENERCA)
Antoniou Z., Schiza EC., Neokleous K., Angastiniotis M., Pattichis CS., Schizas CN. Stud Health Technol Inform. 2015;213:153-6.
The Thalassemia International Federation: A Global Public Health Paradigm
Soteriades, E.S.; Weatherall, D. Thalassaemia Reports 2014, 4, 1840.
Serial Echocardiographic Left Ventricular Ejection Fraction Measurements: A Tool for Detecting Thalassemia Major Patients at Risk of Cardiac Death
Maggio A., Vitrano A., Calvaruso G., Barone R., Rigano P., Mancuso L., et al. Blood Cells Mol Dis. 2013 Apr;50(4):241-6. doi: 10.1016/j.bcmd.2012.12.002.
Are We Strong Enough to Assert Our Rights in Quality Healthcare?
Loris Brunetta. Thalassaemia Reports. 2014, 4(3), 4882.
Haemoglobinopathies in Europe: Health & Migration Policy Perspectives
Aguilar Martinez P., Angastiniotis M., Eleftheriou A., Gulbis B., Mañú Pereira Mdel M., Petrova-Benedict R., Corrons JL. Orphanet J Rare Dis. 2014 Jul 1;9:97. doi: 10.1186/1750-1172-9-97.PMID: 24980780.
Recommendations for Centres of Expertise in Rare Anaemias. The ENERCA White Book
Vives Corrons JL., Mañú Pereira Mdel M., Romeo-Casabona C., Nicolás P., Gulbis B., Eleftheriou A., Angastiniotis M., et al. Thalass. Rep. 2014, 4(3), 4878; https://doi.org/10.4081/thal.2014.4878 – 4 Dec 2014
Liver Disease and Thalassaemia
George Constantinou. Thalassaemia Reports. Rep. 2013, 3(s1), e17; https://doi.org/10.4081/thal.2013.s1.e17
Epidemiology of Non-Transfusion Dependent Thalassaemias: An Emerging Global Concern
Androulla Eleftheriou. Thalassaemia Reports 2013, 3(s1), e9; https://doi.org/10.4081/thal.2013.s1.e9
The Impact of Migrations on the Health Services for Rare Diseases in Europe: The Example of Haemoglobin Disorders
Angastiniotis M., Vives Corrons JL., Soteriades ES., Eleftheriou A. ScientificWorldJournal. 2013;2013:727905. doi: 10.1155/2013/727905. Epub 2013 Mar 18.PMID: 23576907
Cross-Talk Between Available Guidelines for the Management of Patients with Beta-Thalassemia Major
Musallam KM., Angastiniotis M., Eleftheriou A., Porter JB. Acta Haematol. 2013;130(2):64-73. doi: 10.1159/000345734. Epub 2013 Mar 13. PMID: 23485589
Prevention of Thalassaemias and Other Haemoglobin Disorders: Volume 1: Principles
Angastiniotis M., Eleftheriou A., Galanello R., Harteveld CL., Petrou M., Traeger-Synodinos J., Giordano P., Jauniaux E., Modell B., Serour G., authors. Old J, editor.2nd edition. Nicosia (Cyprus): Thalassaemia International Federation; 2013.PMID: 24672827.
International Network on Endocrine Complications in Thalassaemia (I-CET): An Opportunity to Grow
De Sanctis V., Soliman AT., Angastiniotis M., Eleftheriou A., Kattamis Ch., Karimi M., El Kholy M., Elsedfy H., Yassin MA., et al. Georgian Med News. 2012 Apr;(205):52-7.PMID: 22665732
Highlights from the First Thalassaemia Forum on Growth and Endocrine Complications in Thalassemia Doha, (October 2-3, 2011)
De Sanctis V., Elawwa A., Angastiniotis M., Eleftheriou A., Kattamis C., Karimi M., El Kholy M., Elsedfy H., Yassin MA., Fiscina B., Soliman AT. Pediatr Endocrinol Rev. 2012 Mar;9(3):672-9.PMID: 22523836.
Epidemiology of Rare Anaemias in Europe
Gulbis B., Eleftheriou A., Angastiniotis M., Ball S., Surrallés J., Castella M., Heimpel H., Hill A., Corrons JL. Adv Exp Med Biol. 2010;686:375-96. doi: 10.1007/978-90-481-9485-8_22.
Requirements for a Reference or Expert Thalassemia Center: The Structure/Model for Centers Dealing with Chronic/Hereditary Blood Disorders
Angastiniotis M., Eleftheriou A. Hemoglobin. 2009;33 Suppl 1:S204-10. doi:10.3109/03630260903351890.PMID: 20001627
An Electronic Infrastructure for Research and Treatment of the Thalassemias and Other Hemoglobinopathies: The Euro-Mediterranean ITHANET Project
Lederer CW., Basak AN., Aydinok Y., Christou S., El-Beshlawy A., Eleftheriou A. et al. M.Hemoglobin. 2009;33(3):163-76. doi: 10.1080/03630260903089177.PMID: 19657830
Pediatric Endocrinology Reviews. Diabetes, Nutrition, Metabolism. Bone Disease and Endocrine Complications In Thalassaemia. Forward
De Sanctis V., Angastiniotis M., Eleftheriou A. Pediatr Endocrinol Rev. 2008 Oct;6 Suppl 1:71-2.PMID: 19360987
Thalassaemic Bone Disease. An Overview
Angastiniotis M., Eleftheriou A. Pediatr Endocrinol Rev. 2008 Oct;6 Suppl 1:73-80.PMID: 19337159
Guidelines for the Clinical Management of Thalassaemia
Cappellini MD., Cohen A., Eleftheriou A., Piga A., Porter J., Taher A. 2nd Revised edition. Nicosia (CY): Thalassaemia International Federation; 2008.PMID: 24308075
Prevalence of Endocrine Complications and Short Stature in Patients with Thalassaemia Major: A Multicenter Study by the Thalassaemia International Federation (TIF)
De Sanctis V., Eleftheriou A., Malaventura C.; Thalassaemia International Federation Study Group on Growth and Endocrine Complications in Thalassaemia. Pediatr Endocrinol Rev. 2004 Dec;2 Suppl 2:249-55. PMID: 16462705
The Role of The Thalassaemia International Federation in Health Professionals’ Education
Androulla Eleftheriou. Pediatr Endocrinol Rev. 2004 Dec;2 Suppl 2:242-4.PMID: 16462703
An International Survey of Patients with Thalassemia Major and Their Views About Sustaining Life-Long Desferrioxamine Use
Ward A., Caro JJ., Green TC., Huybrechts K., Arana A., Wait S., Eleftheriou A. BMC Clin Pharmacol. 2002 Apr 23;2:3. doi: 10.1186/1472-6904-2-3.PMID: 12015817
Impact of Thalassemia Major on Patients and Their Families
Caro JJ., Ward A., Green TC., Huybrechts K., Arana A., Wait S., Eleftheriou A. Acta Haematol. 2002;107(3):150-7. doi: 10.1159/000057633.PMID: 11978936
Transfusional Transmitted Viruses in Pregnancy
Eleftheriou A., Kalakoutis G., Pavlides N. J Pediatr Endocrinol Metab. 1998;11 Suppl 3:901-14.PMID: 10091164
